跳至主要内容
临床试验/CTRI/2018/02/011939
CTRI/2018/02/011939招募中未知

A PROSPECTIVE, COMPARATIVE, RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SNEC30 (CURCUMA LONGA) IN THE TREATMENT OF ORAL SUBMUCOSAL FIBROSIS

Arbro Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.Patient or his legally accepted representative is willing to give informed consent.
  • 2.Patient is in the age range of 18-65 yrs.
  • 3.Patient clinically diagnosed with OSF (diagnosed on the basis of reduction in interincisal distance on maximum mouth opening and palpable fibrous bands involving oral mucosa).
  • 4.Patient is willing to discontinue the use of tobacco in any form or areca 1-month prior to the commencement of the treatment.

排除标准

  • 未提供

研究者

发起方
Arbro Pharmaceuticals Pvt Ltd

相似试验